These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 30698830)
1. TGF-β1 elevates P-gp and BCRP in hepatocellular carcinoma through HOTAIR/miR-145 axis. Kong J; Qiu Y; Li Y; Zhang H; Wang W Biopharm Drug Dispos; 2019 Feb; 40(2):70-80. PubMed ID: 30698830 [TBL] [Abstract][Full Text] [Related]
2. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein. Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825 [TBL] [Abstract][Full Text] [Related]
3. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related]
4. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies. Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X Tumori; 2010; 96(1):90-6. PubMed ID: 20437864 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma. Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687 [TBL] [Abstract][Full Text] [Related]
6. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions. Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932 [TBL] [Abstract][Full Text] [Related]
7. Chorioamnionitis Induces a Specific Signature of Placental ABC Transporters Associated with an Increase of miR-331-5p in the Human Preterm Placenta. do Imperio GE; Bloise E; Javam M; Lye P; Constantinof A; Dunk C; Dos Reis FM; Lye SJ; Gibb W; Ortiga-Carvalho TM; Matthews SG Cell Physiol Biochem; 2018; 45(2):591-604. PubMed ID: 29402780 [TBL] [Abstract][Full Text] [Related]
8. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference. Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138 [TBL] [Abstract][Full Text] [Related]
9. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer. Zhang L; Li Y; Wang Q; Chen Z; Li X; Wu Z; Hu C; Liao D; Zhang W; Chen ZS Mol Cancer; 2020 Jan; 19(1):10. PubMed ID: 31952518 [TBL] [Abstract][Full Text] [Related]
10. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier. Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692 [TBL] [Abstract][Full Text] [Related]
11. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells. Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266 [TBL] [Abstract][Full Text] [Related]
12. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib. Graber-Maier A; Gutmann H; Drewe J Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289 [TBL] [Abstract][Full Text] [Related]
13. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145. Xiang Y; Zhang Y; Tang Y; Li Q Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533 [TBL] [Abstract][Full Text] [Related]
14. Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells. Lye P; Bloise E; Imperio GE; Chitayat D; Matthews SG Cells; 2022 Jul; 11(14):. PubMed ID: 35883702 [TBL] [Abstract][Full Text] [Related]
15. Effects of P-gp and Bcrp as brain efflux transporters on the uptake of [ Jung KH; Oh SJ; Kang KJ; Han SJ; Nam KR; Park JA; Lee KC; Lee YJ; Choi JY Synapse; 2019 Nov; 73(11):e22123. PubMed ID: 31269310 [TBL] [Abstract][Full Text] [Related]
16. Maternal and Fetal Exposure to (-)-Δ Chen X; Unadkat JD; Mao Q Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608 [TBL] [Abstract][Full Text] [Related]
17. Using the lentiviral vector system to stably express chicken P-gp and BCRP in MDCK cells for screening the substrates and studying the interplay of both transporters. Zhang Y; Huang J; Liu Y; Guo T; Wang L Arch Toxicol; 2018 Jun; 92(6):2027-2042. PubMed ID: 29725709 [TBL] [Abstract][Full Text] [Related]
18. Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters. Volpe DA AAPS J; 2024 Jul; 26(4):79. PubMed ID: 38981917 [TBL] [Abstract][Full Text] [Related]
19. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Han LW; Gao C; Mao Q Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462 [TBL] [Abstract][Full Text] [Related]
20. Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance. Qiu Q; Zou F; Li H; Shi W; Zhou D; Zhang P; Li T; Yin Z; Cai Z; Jiang Y; Huang W; Qian H J Med Chem; 2021 May; 64(9):6179-6197. PubMed ID: 33938746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]